肝硬化中肠道血管相关巨噬细胞与肠血管屏障功能障碍
该研究利用四氯化碳诱导的小鼠肝硬化模型及患者十二指肠活检,结合单细胞转录组分析,发现肝硬化时细菌易位源于上皮细胞死亡、血管屏障损伤及肠血管巨噬细胞功能障碍等多重屏障失败,且耗竭血管内衬巨噬细胞可致细菌系统性播散。
要点
- 肝硬化细菌易位涉及上皮、血管屏障及肠血管巨噬细胞多重关卡失败。
- 肠血管巨噬细胞功能紊乱表现为趋化因子升高、清除细菌能力下降。
- 耗竭血管内衬巨噬细胞足以导致细菌易位至系统部位。
核心结论
- 肝硬化中细菌易位是肠道上皮屏障、血管屏障及肠血管巨噬细胞功能障碍共同作用的结果。
- 肠道巨噬细胞在防止腔內细菌播散中起关键作用,肠血管屏障的重要性被强调。
研究设计与样本
- 研究采用慢性四氯化碳给药长达20周的小鼠肝硬化模型。
- 对肝硬化小鼠及代偿期与失代偿期肝硬化患者的髓系细胞进行单细胞转录组分析,并使用患者来源的肠道活检组织。
主要发现
- 肝硬化时细菌易位与上皮细胞异常死亡、血管屏障损伤及肠血管巨噬细胞功能障碍相关。
- 在肝硬化临床前模型中,巨噬细胞单核细胞趋化因子水平升高、细菌清除减少、与血管相互作用受损。
- 耗竭血管内衬巨噬细胞可导致细菌易位至系统部位,即使在无实验性肝病时亦如此。
- 肝硬化患者十二指肠活检巨噬细胞的转录谱显示支持血管的通路失调及趋化因子表达升高。
临床怎么用
- 关注肠血管屏障及肠血管巨噬细胞功能可能为预防肝硬化细菌易位提供新思路。
- 肠道巨噬细胞在防止腔內细菌播散中的作用提示其作为干预靶点的潜在价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bacterial translocation in cirrhosis can trigger infection and hepatic decompensation, leading to systemic inflammation, organ failure and increased mortality. These infections often originate from the gastrointestinal tract after bacteria breach the intestinal barrier and disseminate to systemic sites. OBJECTIVE: In this study, we explore the mechanisms underlying intestinal barrier dysfunction in cirrhosis using an experimental cirrhosis model and patient-derived intestinal biopsies. DESIGN: We developed a murine model of cirrhosis through chronic administration of carbon tetrachloride for up to 20 weeks. We investigated both the intestinal epithelial and vascular compartments and performed single-cell transcriptomic profiling of myeloid cells isolated from cirrhotic mice and from individuals with compensated and decompensated cirrhosis. RESULTS: Our findings indicate that bacterial translocation in cirrhosis is the result of failure at multiple checkpoints, including aberrant epithelial cell death, vascular barrier damage and dysfunction of gut-vascular macrophages. In a preclinical model of cirrhosis, macrophages exhibited increased levels of monocyte-attracting chemokines, reduced bacterial clearance and impaired interactions with blood vessels. Importantly, depleting vascular-lining macrophages resulted in bacterial translocation to systemic sites, even in the absence of experimental liver disease. Transcriptional profiling of macrophages from duodenal biopsies of patients with cirrhosis indicated similar dysregulation of pathways supporting blood vessels and elevated expression of chemokines. CONCLUSIONS: This study emphasises the critical role of intestinal macrophages in preventing the dissemination of luminal bacteria and highlights the multifaceted breakdown of the intestinal barrier in cirrhosis and the importance of the gut-vascular barrier.
引用
- Smets L, Viola MF, Boesch M, et al. Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis. Gut. 2026. PMID: 41253495. doi:10.1136/gutjnl-2025-335745
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。